Characteristic | Â | n (%) |
---|---|---|
pDILI | Â | 105 |
Sex | Female | 49 (46.7) |
 | Male | 56 (53.3) |
Age (years) | 18–24 | 17 (16.2) |
 | 25–29 | 22 (21.0) |
 | 30–34 | 10 (9.5) |
 | 35–39 | 13 (12.4) |
 | 40–49 | 14 (13.3) |
 | 50–59 | 12 (11.4) |
 | 60+ | 17 (16.2) |
Ethnic origin | Indian | 55 (52.4) |
 | Pakistani | 8 (7.6) |
 | Nepalese | 8 (7.6) |
 | Afghan | 2 (1.9) |
 | Somali | 4 (3.8) |
 | Romanian | 2 (1.9) |
 | Black | 6 (5.7) |
 | White | 11 (10.5) |
 | Asian (Other) | 7 (6.7) |
 | Other | 2 (1.9) |
Site of tuberculosis | Â | Â |
Pulmonary | Â | 21 (20) |
Extrapulmonary | Â | 61 (58.1) |
Both | Â | 23 (21.9) |
Total culture confirmed | Â | 62 (59) |
Fully sensitive TB | Â | 56 (53.3) |
Isoniazid monoresistant TB | Â | 3 (2.9) |
Multi-drug resistant TB | Â | 3 (2.9) |
HIV positive | Â | 8/96 (7.6) |
HCV positive (detectable RNA) | Â | 3/98 (3.0) |
HBV positive | Â | 0/101 (0) |
Alcohol Excessa | Â | 9/105 (8.6) |
Chronic Liver Diseaseb | Â | 7/105 (6.7) |
No risk factorc | Â | 78/105 (74.2) |
Other risk factors | Â | Median (IQR), n |
Baseline ALT (IU/L) (normal range 10–50) | 24 (17–32), n = 77 | |
Baseline ALP (IU/L) (normal range 30–130) | 98 (75–135), n = 77 | |
Baseline BILI (umol/L) (normal range 0–21) | 8 (6–12), n = 77 | |
Weight (kg) |  | 53.9 (48.0–65.0), n = 74 |
Rifampicin dose per kg | (if given) | 9.98 (9.00–11.1), n = 74 |
Isoniazid dose per kg | (if given) | 5.57 (4.62–6.25), n = 74 |
Pyrazinamide dose per kg | (if given) | 25.8 (22.7–29.8), n = 74 |
Moxifloxacin dose per kg | (if given) | 7.34 (6.15–8.15), n = 36 |